Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | Not yet disclosed by govt. | 13 | - |
| 2 | Schedule 2 | PHARMA (INDIA) | 5 | ₹2,880 |
| 3 | Schedule 3 | PHARMA (INDIA) | 4 | ₹14,760 |
| 4 | Schedule 4 | Not yet disclosed by govt. | 13 | - |
| 5 | Schedule 5 | FAIRDEAL HEALTH CARE PRIVATE LIMITED | 3 | ₹8,184 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
21 May 2026, 12:00 pmClosed
REPAGLINIDE 0.5 MG TAB
RISPERIDONE 2 MG TAB
ROPINIROLE 1 MG TAB
ROSUVASTATIN 10 MG TAB
SERTRALINE 25 MG TAB
SILODOSIN 4 MG TAB
SODIUM BICARBONATE 1000 MG TAB
9287550
GEM/2026/B/7502159
Two Packet Bid
REPAGLINIDE 0.5 MG TAB,RISPERIDONE 2 MG TAB,ROPINIROLE 1 MG TAB,ROSUVASTATIN 10 MG TAB,SERTRALINE 2
Mumbai, Maharashtra
Item wise evaluation
BOQ
7 documents required · 7 mandatory
2 yrs
₹1 L
₹1 L
20%
Exempted
Yes
21 May 2026
11 May 2026
21 May 2026
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | REPAGLINIDE 0.5 MG TAB | 6,000 | NO | Mumbai | 30 |
| 2 | RISPERIDONE 2 MG TAB | 9,600 | NO | Mumbai | 30 |
| 3 | ROPINIROLE 1 MG TAB | 9,000 | NO | Mumbai | 30 |
| 4 | ROSUVASTATIN 10 MG TAB | 1,26,000 | NO | Mumbai | 30 |
| 5 | SERTRALINE 25 MG TAB | 13,200 | NO | Mumbai | 30 |
| 6 | SILODOSIN 4 MG TAB | 39,000 | NO | Mumbai | 30 |
| 7 | SODIUM BICARBONATE 1000 MG TAB | 21,000 | NO | Mumbai | 30 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_9287550.pdf
GEM_BID • 0.14 MB
bbqr-rr_2026-05-05-10-00-36_ae2184e49dbf00d4c30419b31fe70dd9.pdf
BOQ • 0.31 MB
boq_item_sample_file-2_2026-05-05-10-00-36_a1d8ecdcd57e4a27c02d7c22f5b12380.csv
BOQ • 0.00 MB
gtc.pdf
GEM_OTHER • 0.71 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .